CSA
Medical, Inc. is
committed to bringing the proven science of cryotherapy
to endoscopy. With the CSA™ System,
therapeutic endoscopists will have the ability
to quickly and easily ablate unwanted tissue.
The CSA™ System utilizes
a patented technology that regulates and transports
a low-pressure cryogen through the CSA™ Catheter,
an open-tipped 7Fr catheter that is easily passed
through a standard endoscope. This rapid delivery system
of repetitive freeze-thaw cycles has been shown in
clinical studies to ablate pre-cancerous and cancerous
cells with subsequent regrowth of normal esophageal
epithelium.
|
|
Anticipated
CSA™ Patient Benefits
Simple. Comfortable.
Minimal time.
No photosensitivity.
Same day return to normal routine. |
|
|
Physicians
Finally,
an endoscopic system designed to quickly and safely
ablate tissue under direct visualization. |
|
|
| The
CSA™ Treatment |
BEFORE |
Direct
Visualization
• Safe, simple and effective
• Enhances accuracy and control
• Frequently eliminates the need for salvage therapies often associated
with missed and/or untreated lesions
|
DURING |
Physician-Controlled
CryoSpray
• Offers the advantages of a low-pressure delivery system with a cryogen
at -196°C
• Direct visualization of CryoSpray targeted to focal and large areas
• Capable of treating focal and broad lesions with varying depth of injury
|
AFTER |
Rapid
Cooling
• Initiates programmed cell death (apoptosis)
• Stimulates the cryoimmune response
• Achieves delayed injury
• Short procedure time
• Improves patient tolerance |
|
